计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| F421601-1ml |
1ml |
现货 ![]() |
|
| 别名 | 1,4-二氢-1-[(2R)-2-(2-甲氧基苯基)-2-[(四氢-2H-吡喃-4-基)氧基]乙基]-alpha,alpha,5-三甲基-6-(2-恶唑基)-2,4-二氧代噻吩并[2,3-d]嘧啶-3(2H)-乙酸 | 菲索科斯塔 (GS-0976) |
|---|---|
| 英文别名 | FIRSOCOSTAT [WHO-DD] | ND-630; NDI-010976; Firsocostat | FIRSOCOSTAT [INN] | BS-15388 | THIENO(2,3-D)PYRIMIDINE-3(2H)-ACETIC ACID, 1,4-DIHYDRO-1-((2R)-2-(2-METHOXYPHENYL)-2-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)ETHYL)-.ALPHA.,.ALPHA.,5-TRIMETHYL-6-(2-OXAZOLYL)-2 |
| 规格或纯度 | Moligand™, 10mM in DMSO |
| 英文名称 | Firsocostat (GS-0976) |
| 生化机理 | Firsocostat(GS-0976,NDI-010976,ND-630)是乙酰辅酶羧化酶(ACC)的可逆抑制剂,对 hACC1 和 hACC2 的 IC50 分别为 2.1 nM 和 6.1 nM。 |
| 储存温度 | -80℃储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 变构调节剂 |
| 作用机制 | 乙酰辅酶羧化酶 1 的异构调节剂;乙酰辅酶羧化酶 2 的异构调节剂 |
| 产品介绍 |
Firsocostat (GS-0976, NDI-010976, ND-630)是acetyl CoA carboxylase (ACC)的一种可逆抑制剂,对hACC1和hACC2的IC50分别为2.1 nM,6.1 nM。 Information Firsocostat (GS-0976) Firsocostat (GS-0976, NDI-010976, ND-630) is a reversible inhibitor of acetyl CoA carboxylase (ACC) with IC50s of 2.1 nM,6.1 nM for hACC1 and hACC2,respectively. Targets hACC1 (Cell-free assay); hACC2 (Cell-free assay) 2.1 nM; 6.1 nM In vitro When ND-630 and [14C]acetate were administered to Hep-G2 cells for 4 h, ND-630 inhibited FASyn with EC50 values of 66 nM in cells cultured in medium containing. When ND-630 and[14C]palmitate were administered to C2C12 cells for 6 h, ND-630 increased both the release of [14C]O2 and the production of[14C]acid-soluble material. In vivo When administered chronically to rats with diet-induced obesity, ND-630 reduces hepatic steatosis, improves insulin sensitivity, reduces weight gain without affecting food intake, and favorably affects dyslipidemia. |
| ALogP | 2.946 |
|---|---|
| Rotatable Bond | 9 |
| 分子类型 | 小分子 |
|---|---|
| IUPAC Name | 2-[1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno[2,3-d]pyrimidin-3-yl]-2-methylpropanoic acid |
| INCHI | InChI=1S/C28H31N3O8S/c1-16-21-24(32)31(28(2,3)26(33)34)27(35)30(25(21)40-22(16)23-29-11-14-38-23)15-20(39-17-9-12-37-13-10-17)18-7-5-6-8-19(18)36-4/h5-8,11,14,17,20H,9-10,12-13,15H2,1-4H3,(H,33,34)/t20-/m0/s1 |
| InChi Key | ZZWWXIBKLBMSCS-FQEVSTJZSA-N |
| Canonical SMILES | CC1=C(SC2=C1C(=O)N(C(=O)N2CC(C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5 |
| Isomeric SMILES | CC1=C(SC2=C1C(=O)N(C(=O)N2C[C@@H](C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5 |
| PubChem CID | 71528744 |
| 分子量 | 569.63 |
| DMSO(mg / mL) Max Solubility | 100 |
|---|---|
| DMSO(mM) Max Solubility | 175.552551656338 |
| Water(mg / mL) Max Solubility | <1 |
| 分子量 | 569.600 g/mol |
| XLogP3 | 3.200 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 10 |
| 可旋转键计数Rotatable Bond Count | 9 |
| 精确质量Exact Mass | 569.183 Da |
| 单同位素质量Monoisotopic Mass | 569.183 Da |
| 拓扑极表面积Topological Polar Surface Area | 160.000 Ų |
| 重原子数Heavy Atom Count | 40 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 947.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| Concentration(Compounding value) | 9.0-11.0(mmol/L) |
|---|---|
| Appearance(Colorless Transparent Liquid) | Pass |
| Record the entire process by video | Conform |